BlueBay and HSBC provide debt for £83m Synexus buyout
BlueBay and HSBC have provided debt to support a secondary buyout of Synexus, the UK clinical trials coordinator, by LDC, the private equity arm of Lloyds Bank.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts